Cleared Traditional

K253050 - RadOncAI

K253050 is an FDA 510(k) clearance for RadOncAI, manufactured by Informai. The device is a Class 2 Radiology device with product code MUJ cleared through the Traditional 510(k) pathway after a 269-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2026
Decision
269d
Days
Class 2
Risk

K253050 is an FDA 510(k) clearance for the RadOncAI. Classified as System, Planning, Radiation Therapy Treatment (product code MUJ), Class II - Special Controls.

Submitted by Informai (Houston, US). The FDA issued a Cleared decision on June 18, 2026 after a review of 269 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Informai devices

FDA 510(k) Submission Details - K253050

510(k) Number K253050 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 22, 2025
Decision Date June 18, 2026
Days to Decision 269 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
162d slower than avg
Panel avg: 107d · This submission: 269d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MUJ Device Classification - Class 2, Special Controls

Product Code MUJ System, Planning, Radiation Therapy Treatment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MUJ System, Planning, Radiation Therapy Treatment

All 146
Devices cleared under the same product code (MUJ) and FDA review panel - the closest regulatory comparables to K253050.
Virtual Cone (1.0)
K260750 · Varian Medical Systems, Inc. · Jul 2026
Multimodality Simulation Workspace (MM Sim) (v1.0.0)
K260207 · Philips Medical Systems Nederland B.V. · May 2026
eXaSkin Plus
K252784 · Anatomical Geometry S.L. · May 2026
ART.1-US
K253078 · Seetreat Pty, Ltd. · May 2026
syngo.via RT Image Suite VC10
K252304 · Varian Medical Systems, Inc. · Mar 2026
Monaco RTP System (6.3)
K252002 · Elekta Solutions AB · Feb 2026